News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Year: 2022

Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AGEpigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 11.05.2022 / 15:38 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of […]

Read more

Epigenomics AG Reports Financial Results for the First Quarter of 2022

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter ResultsEpigenomics AG Reports Financial Results for the First Quarter of 2022 11.05.2022 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Quarter of 2022 Berlin (Germany) and San Diego, CA (U.S.A.), May 11, […]

Read more

Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AGEpigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 10.05.2022 / 17:39 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of […]

Read more

Epigenomics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung

Epigenomics AGEpigenomics AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung 27.04.2022 / 20:38 Veröffentlichung einer Stimmrechtsmitteilung übermittelt durch DGAP – ein Service der EQS Group AG.Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Stimmrechtsmitteilung 1. Angaben zum Emittenten Name: Epigenomics AG Straße, Hausnr.: Geneststraße 5 PLZ: […]

Read more

Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG / Total Voting Rights AnnouncementEpigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 27.04.2022 / 09:58 Total Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Publication […]

Read more

​​​​​​​Epigenomics AG Reports Financial Results for Fiscal Year 2021

DGAP-News: Epigenomics AG / Key word(s): Annual Report/Annual Results24.03.2022 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for Fiscal Year 2021 Total revenue of EUR 6.2 million, adjusted EBITDA of EUR -1.8 million FDA clinical trial for Epi proColon “Next Gen” expected to start with […]

Read more